Supply of Ophthalmic Antibiotic Medication – Trimethoprim and Polymyxin B Sulfates

The contract outlines the procurement and delivery of eight bottles of an ophthalmic antibiotic solution containing Trimethoprim and Polymyxin B Sulfates, specifically aligned with federal pharmaceutical standards and Defense Logistics Agency logistics protocols. The medication is intended for military medical use and must meet stringent quality and safety requirements mandated by the Department of Defense, ensuring sterility, potency, and compliance with FDA regulations for ophthalmic applications. Delivery timelines and packaging specifications are governed by DLA’s supply chain procedures to support readiness and distribution across military healthcare facilities. This subcontract, identified under NAICS code 325412 for pharmaceutical preparation manufacturing, is managed under the Defense Logistics Agency’s procurement system with the contract award reference SPE2DX25D9900 and delivery record SPE2DP26F8745. While no solicitation number or set-aside details are provided, the posting date of August 5, 2026, indicates this is a future-facing procurement. The place of performance and point of contact information are not specified, suggesting logistics coordination will be handled centrally through DLA’s network. All units must be labeled, documented, and shipped per federal pharmaceutical and military supply standards to ensure traceability and compliance upon receipt.